Gestational trophoblastic disease (GTD) 
INTRODUCTION
Gestational trophoblastic neoplasm (GTN) represents a spectrum of pathologic and clinical alterations, ranging from molar pregnancy to metastatic gestational trophoblastic neoplasm (1) . Metastatic tumors develop after a complete molar pregnancy, but they are more common after non-molar pregnancies. The most common sites of GTN metastases are the lungs, vagina, pelvis, liver, and brain. Trophoblastic tumors are highly vascular and prone to severe hemorrhage, either spontaneous or during biopsy. Patients with pulmonary metastases may have hemoptysis, dyspnea, chest pain, bloody effusion, and hypovolemia. Because respiratory symptoms and a radiological finding may be dramatic, the patient may be thought to have primary pulmonary disease (2, 3) . Regrettably, the diagnosis of GTN may be confirmed only after thoracotomy has been performed, particularly in patients with a non-molar antecedent pregnancy. In patients with GTN, gynecological symptoms are sometimes ignored (4).
CASE REPORT
A 34-year-old female patient was admitted for complaints of left pleuritic chest pain, cough with occasional hemoptysis, subfebrile temperature (the highest 38 o C) of three months duration. She also had amenorrhea for two months. Her menstrual history was normal and the previous pregnancy had been term delivered. Clinical examination showed a mildly anemic young woman without jaundice, or significant lymphadenopathy. She had dull note on percussion on the left side. Breath sounds and vocal resonance was decreased on the same side. Liver and spleen were not palpable. A chest radiograph on hospital admission revealed a large well-circumscribed mass in the left lower zone, which subsequently enlarged invading the pleura ( Figure 1 ). Pleural fluid was hemorrhagic and malignant cells were not identified. Pleural biopsy suggested metastatic choriocarcinoma. Pleural fluid and urine HCG were 800,000 IU/L and 4500,000 IU/L respectively as detected by slide latex agglutination test. Blood count was in the normal range. The USG of pelvis and a detailed gynecological examination showed a soft cystic mass around 6 cm in the posterior fornix on the left side. The patient was prepared for chemotherapy and irradiation. First dosage of vincristine, methotrexate, and chlorambucil was administered. In the meantime, she developed a left sided hemiplegia following headache. MRI was reported as hemorrhagic tumor in left parietal lobe with significant mass effect and surrounding edema. The general condition deteriorated and the rapid reaccumulation of pleural fluid necessitated intercostal tube thoracostomy. The patient died on the 14th hospital day. 
DISCUSSION
Choriocarcinoma is a malignant tumor of the trophoblast and generally follows an identifiable gestational event. Approximately 50% of choriocacinomas occur after a molar pregnancy, 25% after an abortion, and 22% after a normal pregnancy (5). Metastatic gestational trophoblastic neoplasm has a propensity for early vascular invasion and dissemination. Patients may present with signs and symptoms of bleeding from metastases such as hemoptysis, hepatic rupture, or acute neurological deficits (4). GTN is extremely responsive to chemotherapy. Therefore, chemotherapy is the main modality of treatment in patients with GTN even in its metastatic forms (4) . Early recognition of GTN will maximize the chances of curing with chemotherapy. Clinicians should be aware of the possibility of GTN in any reproductive-aged woman with bizarre central nervous system symptoms, gastrointestinal, pulmonary symptoms, or radiographic evidence of metastatic tumor of unknown primary origin. The initial roentgenographic presentation in our patient was a large pulmonary mass, which subsequently invaded the pleura, giving rise to a massive www.onk.ns.ac.rs/Archive Vol 18, No. 3, October 2010 effusion. Pleural biopsy in this patient prompted us to look for HCG not only in urine but also in pleural fluid. we would like to emphasize that detection of HCG in pleural fluid and urine/serum form part of the diagnostic work of such female patients with hemorrhagic pleural effusion. This is a simple, non-invasive, quick bedside procedure and helps in the early diagnosis and institution of prompt therapy, which is so crucial for prognosis. Our patient had poor prognosis, metastatic gestational neoplasia by virtue of her antecedent term pregnancy and symptoms of over three months. Hammond et al (6) distinguished a metastatic gestational neoplasia of poor prognosis by the presence of one or more of the following: urinary HCG levels elevated to more than 10,000 IU/L or serum HCG levels more than 40,000 mIU/L (B HCG RIA), symptoms of malignancy present for longer than four months, brain or liver metastases, unsuccessful previous chemotherapy and antecedent term pregnancy. It appears that detection of HCG in pleural fluid in metastatic gestational neoplasia can be added up to this list indicating poor prognosis. Another factor, which tilted the clinical course against our patient, is the development of brain metastases, while she was under chemotherapy. The prognosis in patients who develop cerebral metastases while under chemotherapy has been found to be worse than in patients initially with such metastases. Aggressive multi-agent chemotherapy with adjuvant irradiation or surgical therapy forms the cornerstone of management of poor prognosis metastatic gestational trophoblastic neoplasm (6, 7) . However, such combined modality treatment was not possible in our patient even though chemotherapy and irradiation was initially planned.
